Physicians routinely prescribe an infusion containing gadolinium to enhance MRI scans, but there is evidence that nanoparticles of the toxic rare earth metal infiltrate kidney cells, sometimes triggering severe side effects, ...
Feb 17, 2023
1
1090
Tai chi, the Chinese martial art that involves sequences of very slow controlled movements, may curb the symptoms and complications of Parkinson's disease for several years, reveals research published online in the Journal ...
Oct 24, 2023
1
561
One injection of an antibody treatment let people with severe peanut allergies eat a nut's worth of peanut protein two weeks later, a small, Stanford-led pilot study showed.
Nov 14, 2019
0
7045
Scientists at the University of East Anglia are a step closer to creating a new generation of light-activated cancer treatments. The futuristic-sounding treatment would work by switching on LED lights embedded close to a ...
Feb 16, 2023
0
72
A team of researchers at the New York-Presbyterian/Weill Cornell Medical Center announced that a woman they have been treating for both HIV and leukemia has apparently been cured of HIV—14 months after discontinuing antivirals, ...
Researchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesized a small molecule that could be a more accessible and effective alternative to an antibody that is successfully used to ...
Aug 8, 2022
0
3679
A $4.5 billion initiative to sequence the genomes of three million Africans would not only benefit a continent long neglected in gene-based healthcare, but advance understanding of genetic disease worldwide, the project leader ...
Feb 11, 2021
0
301
An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...
Nov 3, 2022
0
2102
A brand-new kind of drug, tested in mice, shows promising new results that could lead to the development of a new weight-loss drug that mimics exercise.
Sep 25, 2023
0
90
US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.
Jan 17, 2023
0
20
